Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tremblant Capital Group is a global investment management firm headquartered in New York City. Founded in 2001 by Brett Barakett, the firm specializes in a fundamental, bottom-up investment process focused on global equity markets. While Tremblant is a significant institutional investor in the healthcare, biotechnology, and life sciences sectors, it operates as a financial services entity rather than a clinical-stage developer or manufacturer. The firm manages various investment vehicles, including long/short and long-only equity funds, utilizing deep industry research to identify high-conviction growth opportunities. Tremblant is recognized for its disciplined approach to capital management and its focus on long-term value creation across diverse sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tremblant Capital Group.